Literature DB >> 21308261

The influence of the comorbidity between depression and alcohol use disorder on suicidal behaviors in the São Paulo Epidemiologic Catchment Area Study, Brazil.

Bruno Mendonça Coêlho1, Laura Helena Andrade, Francisco Bevilacqua Guarniero, Yuan-Pang Wang.   

Abstract

OBJECTIVE: To investigate in a community sample the association of suicide-related cognitions and behaviors ("thoughts of death", "desire for death", "suicidal thoughts", and "suicidal attempts") with the comorbidity of depressive disorders (major depressive episode or dysthymia) and alcohol or substance use disorders.
METHOD: The sample was 1464 subjects interviewed in their homes using the Composite International Diagnostic Interview to generate DSM-III-R diagnosis. Descriptive statistics depicted the prevalence of suicide-related cognitions and behaviors by socio-demographic variables and diagnoses considered (major depressive episode, dysthymia, alcohol or substance use disorders). We performed a multivariate logistic regression analysis to estimate the effect of comorbid major depressive episode/dysthymia and alcohol or substance use disorders on each of the suicide-related cognitions and behaviors.
RESULTS: The presence of major depressive episode and dysthymia was significantly associated with suicide-related cognitions and behaviors. In the regression models, suicide-related cognitions and behaviors were predicted by major depressive episode (OR=range 2.3-9.2) and dysthymia (OR=range 5.1-32.6), even in the presence of alcohol use disorders (OR=range 2.3-4.0) or alcohol or substance use disorders (OR=range 2.7-2.8). The interaction effect was observed between major depressive episode and alcohol use disorders, as well as between dysthymia and gender. Substance use disorders were excluded from most of the models.
CONCLUSION: Presence of major depressive episode and dysthymia influences suicide-related cognitions and behaviors, independently of the presence of alcohol or substance use disorders. However, alcohol use disorders and gender interact with depressive disorders, displaying a differential effect on suicide-related cognitions and behaviors.

Entities:  

Mesh:

Year:  2010        PMID: 21308261     DOI: 10.1590/s1516-44462010005000027

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  6 in total

1.  Characterizing the phenomenology of passive suicidal ideation: a systematic review and meta-analysis of its prevalence, psychiatric comorbidity, correlates, and comparisons with active suicidal ideation.

Authors:  Richard T Liu; Alexandra H Bettis; Taylor A Burke
Journal:  Psychol Med       Date:  2020-01-07       Impact factor: 7.723

2.  Alcohol-related risk of suicidal ideation, suicide attempt, and completed suicide: a meta-analysis.

Authors:  Nahid Darvishi; Mehran Farhadi; Tahereh Haghtalab; Jalal Poorolajal
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

3.  Depressive symptoms in patients diagnosed with benign prostatic hyperplasia.

Authors:  Barbara Pietrzyk; Magdalena Olszanecka-Glinianowicz; Aleksander Owczarek; Tomasz Gabryelewicz; Agnieszka Almgren-Rachtan; Andrzej Prajsner; Jerzy Chudek
Journal:  Int Urol Nephrol       Date:  2015-02-12       Impact factor: 2.370

4.  Hazardous drinking-related characteristics of depressive disorders in Korea: the CRESCEND study.

Authors:  Seon-Cheol Park; Sang Kyu Lee; Hong Seok Oh; Tae-Youn Jun; Min-Soo Lee; Jae-Min Kim; Jung-Bum Kim; Hyeon-Woo Yim; Yong Chon Park
Journal:  J Korean Med Sci       Date:  2014-12-23       Impact factor: 2.153

5.  Incidence and Risk Factors of Post-Operative Depression in Patients Undergoing Transurethral Resection of Prostate for Benign Prostatic Hyperplasia.

Authors:  Daofang Zhu; Jingjing Gao; Xianming Dou; Dangwei Peng; Yao Zhang; Xiansheng Zhang
Journal:  Int J Gen Med       Date:  2021-11-09

6.  Substance use and suicidal ideation and behaviour in low- and middle-income countries: a systematic review.

Authors:  Elsie Breet; Daniel Goldstone; Jason Bantjes
Journal:  BMC Public Health       Date:  2018-04-24       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.